Eisele Jeffrey
- SEC CIK
- 0001827326
No open-market purchases or sales filed in the past year.
Current role at each company
- APLS Apellis Pharmaceuticals, Inc.Chief Development Officeras of Jan 30, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Eisele Jeffrey as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 (view filing) | Jan 29 | 1 day | Eisele JeffreyChief Development Officer | SSale | −278 | $29.52 | −$8.21K | −0.5%55.3K after | |
| Jan 23, 2025 (view filing) | Jan 22 | 1 day | Eisele JeffreyChief Development Officer | SSale | −1.29K | $30.43 | −$39.3K | −2.3%55.6K after | |
| Jan 14, 2025 (view filing) | Jan 13 | 1 day | Eisele JeffreyChief Development Officer | SSale | −264 | $28.70 | −$7.58K | −0.5%56.9K after | |
| Dec 27, 2024 (view filing) | Dec 23 | 4 days | Eisele JeffreyChief Development Officer | SSale | −63 | $33.09 | −$2.08K | −0.1%57.1K after | |
| Jan 31, 2024 (view filing) | Jan 29-30 | 2 days | Eisele JeffreyChief Development Officer | SSale | −1.25K | $65.22 | −$81.5K | −2.1%57.2K after | 2 lots10b5-1 |
| Jan 24, 2024 (view filing) | Jan 23 | 1 day | Eisele JeffreyChief Development Officer | SSale | −7.38K | $63.69 | −$469.9K | −11.2%58.5K after | 10b5-1 |
| Jan 23, 2024 (view filing) | Jan 22 | 1 day | Eisele JeffreyChief Development Officer | SSale | −1.61K | $65.00 | −$104.5K | −2.4%65.8K after | |
| Jan 18, 2024 (view filing) | Jan 17 | 1 day | Eisele JeffreyChief Development Officer | SSale | −5.21K | $65.58 | −$341.5K | −7.2%67.4K after | 10b5-1 |
| Jan 17, 2024 (view filing) | Jan 16 | 1 day | Eisele JeffreyChief Development Officer | SSale | −438 | $66.81 | −$29.3K | −0.6%72.7K after | |
| Dec 28, 2023 (view filing) | Dec 26-27 | 2 days | Eisele JeffreyChief Development Officer | SSale | −303 | $59.70 | −$18.1K | −0.6%53.6K after | 2 lots10b5-1 |
| Feb 27, 2023 (view filing) | Feb 23 | 4 days | Eisele JeffreyChief Development Officer | SSale | −1.65K | $68.76 | −$113.2K | −3.0%53.9K after | |
| Jan 31, 2023 (view filing) | Jan 30 | 1 day | Eisele JeffreyChief Development Officer | SSale | −883 | $52.76 | −$46.6K | −1.9%46.5K after | |
| Jan 25, 2023 (view filing) | Jan 23 | 2 days | Eisele JeffreyChief Development Officer | SSale | −4.48K | $51.58 | −$231.0K | −8.6%47.7K after |